Trend Signal Now: The Hot Corner: Baker Bros. Advisors Reports a $24 Million IMCR Buy

Thursday, March 20, 2025

Today's big story is a Form 4 filing from one of the most successful biotech investors in the world.

📌Baker Bros. Advisors LP revealed a $24 million purchase of Immunocore Holdings $IMCR.

We always keep a close eye on Baker Bros. They're the ultimate bellwether in biotech.

Their track record of spotting early-stage winners and riding them higher is second to none.

Simply put, when Baker Bros. buy, the biotech world takes notice.

And so do we.

Here's The Hot Corner, with data from March 19, 2025:

Click the table to enlarge it.

📌 Bitwise Bitcoin ETF $BITB

Sen. David H. McCormick disclosed a purchase in the amount of $50,001 to $100,000, continuing a trend of lawmakers dipping into crypto-related plays, following recent $MSTR and $BTC-adjacent buys.

📌 Amazon $AMZN

Rep. Scott Franklin put between $50,001 and $100,000 into the e-commerce and cloud services giant.

This is one of the market's most important names (carrying weight in the $DJIA, the $SPX, and the $NDX), currently testing an important polarity level.

We Have a System for It

It's a mess out there. But – despite the down market – we just booked a 10-trade win streak.

We're multiplying more breakouts than ever right now.

Join us – risk-free – and see how we do it.

The Hot Corner Insider

Here's what's happening with The Hot Corner Insider:

We get together on Wednesdays for the Hot Corner Insider Weekly Strategy Session. And we compile the recordings from each and every one in the Strategy Session Archive.

Note that all actionable setups we discuss in The Hot Corner Insider are compiled on the Trade Ideas page.

And please reach out if you have any questions.

Alfonso Depablos | Senior Analyst, All Star Charts

Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media.

Want to change how you receive these emails? You can manage your preferences here

unsubscribe